DrugPatentWatch Database Preview
Litigation Details for MYLAN LABORATORIES LIMITED v. FOOD AND DRUG ADMINISTRATION (D.C. 2012)
» See Plans and Pricing
MYLAN LABORATORIES LIMITED v. FOOD AND DRUG ADMINISTRATION (D.C. 2012)
Docket | Start Trial | Date Filed | 2012-10-02 |
Court | District Court, District of Columbia | Date Terminated | 2013-01-03 |
Cause | 05:551 Administrative Procedure Act | Assigned To | John D. Bates |
Jury Demand | None | Referred To | |
Patents | 6,294,197 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in MYLAN LABORATORIES LIMITED v. FOOD AND DRUG ADMINISTRATION
Details for MYLAN LABORATORIES LIMITED v. FOOD AND DRUG ADMINISTRATION (D.C. 2012)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2012-10-02 | 1 | including U.S. Patent Nos. 5,399,578 (“the ‘578 patent”); 5,972,990 (“the ‘990 patent”); and 6,294,197 (“the ‘…approving the NDA, FDA publishes this patent information in the Patent and Exclusivity Infoirnation Addendum…to each patent properly listed in the Orange Book for the NDA drug: (I) that there is no patent inforrnation…the listed patent, a so-called “paragraph III certification;” or (IV) that the listed patent is invalid… ‘197 patent”). FDA subsequently listed the ‘578, ‘990 and ‘197 patents in the Orange Book in connection | External link to document | |
2012-12-27 | 56 | the '578 patent), 5,972,990 (the '990 patent), and 6,294,197 (the '197 patent). Ranbaxy'… there is no patent information; (II) that the patent has expired; (III) that the patent is set to expire…the patent holder of the certification, and the patent holder then has 45 days to bring a patent infringement… on any patent that claims the drug or a method of using the drug. Id. FDA lists this patent information…Diovan. Id. at 3. Three patents for Diovan are listed in the Orange Book: U.S. Patent Nos. 5,399,578 (the | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |